A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE)

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 14, 2022

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2030

Conditions

Kidney Transplantation

Interventions

BIOLOGICAL

TCD601

Investigational Product

Trial Locations (3)

Mayo Clinic, Rochester

Massachusetts General Hospital, Boston

Samsung Medical University, Seoul

All Listed Sponsors

lead

ITB-Med LLC

INDUSTRY